Egualia, the Italian association representing the manufacturers of generic, biosimilar, shares the ECs objective of ensuring security of supply for critical medicines and strengthening Europe's pharmaceutical resilience. However, we believe that the current proposal does not go far enough in addressing the structural vulnerabilities of the off-patent medicines sector.
EGU
EGUALIA
Industry association · Italy · EU Transparency Register 856838295034-76
2
positions filed
in the 673 files tracked
1
legislative file
of 673 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1528 trade and business associations on this site, they rank #1191 by legislative files engaged, a count of participation, not a measure of influence.
1.4
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2024
in the register since
Declares membership of
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026).
- Register category
- Trade and business associations
- Registered as
- Egualia
- Head office
- Roma, Italy
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track EGUALIA in PolicySpeak: request access →
Work at EGUALIA? so we know who speaks for it.
Their record over time
EGUALIA filed 2 positions between 27 Feb 2025 and 19 Jun 2025, across 1 of the 673 legislative files tracked here.
What they argued
The Critical Medicines Act must lead to a resilient, competitive, and sustainable off-patent pharmaceutical industry. It must ensure secure supply chains, reward investment and strengthen Europes autonomy in critical medicines. 1.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put EGUALIA next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from EGUALIA’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.